The addition of capnography to standard monitoring reduces hypoxemic events during gastrointestinal endoscopic sedation: a systematic review and meta-analysis
Received 19 May 2018
Accepted for publication 16 July 2018
Published 6 September 2018 Volume 2018:14 Pages 1605—1614
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Professor Garry Walsh
Seung Hyun Kim,1 Minsu Park,2 Jinae Lee,2 Eungjin Kim,1 Yong Seon Choi3
1Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea; 2Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea; 3Department of Anesthesiology and Pain Medicine, Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea
Background: The use of capnography monitoring devices has been shown to lower the rates of hypoxemia via early detection of respiratory depression, and facilitate more accurate titration of sedatives during procedures. The aim of the current meta-analysis was to compare the incidence of hypoxemia associated with standard monitoring alone during gastrointestinal endoscopy to that associated with standard monitoring with the addition of capnography.
Methods: The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials scientific databases were searched to identify relevant studies. We performed a meta-analysis of randomized controlled trials undertaken up to January 2018 that met our predefined inclusion criteria. The study outcome measures were incidence of hypoxemia, severe hypoxemia, apnea, the use of assisted ventilation, the use of supplemental oxygen, and change in vital signs.
Results: We included nine trials assessing a total of 3,088 patients who underwent gastrointestinal procedural sedation. Meta-analysis of study outcome revealed that capnography significantly reduced the incidence of hypoxemia (odds ratio 0.61, 95% CI 0.49–0.77) and severe hypoxemia (odds ratio 0.53, 95% CI 0.35–0.81). However, there were no significant differences in other outcomes including incidence of apnea, assisted ventilation, supplemental oxygen, and changes in vital signs. Early procedure termination and patient satisfaction-related outcomes did not differ significantly in the capnography group and the standard monitoring group.
Conclusion: This study indicates that capnography monitoring is an important addition with regard to the detection of hypoxemia during gastrointestinal procedural sedation, and should be considered in routine monitoring during gastrointestinal endoscopy.
Keywords: endoscopy, additional monitoring, hypoxemia, apnea
Sedation and analgesia are commonly used during gastrointestinal endoscopic procedures, and have been shown to increase the success rates of these procedures.1 However, the use of sedative agents can result in respiratory depression, airway obstruction, hypoxemia, and adverse cardiopulmonary events.2,3 Therefore, monitoring of vital signs including continuous pulse oximetry combined with a patient’s breathing pattern is advocated in many national guidelines on sedation for gastrointestinal endoscopy.4,5
Capnography measures the carbon dioxide (CO2) concentration throughout the respiratory cycle, which allows for real-time evaluation of a variety of respiratory factors including respiratory depression, apnea, and hypercapnia.6 Hypoventilation can occur in the presence of normal arterial oxygen saturation as determined via pulse oximetry (SpO2), and inadequate ventilation can precede hypoxemia by several minutes.7,8 The use of a capnography monitoring device has been shown to lower the rates of hypoxemia via early detection of respiratory depression and facilitate more accurate titration of sedatives during procedures.9
The American Society of Anesthesiologists recommended that capnography monitoring should be considered for all patients receiving deep sedation.5 However, there are insufficient data to demonstrate that improved clinical outcomes or care quality derive from the use of capnography in patients undergoing targeted moderate sedation for upper endoscopy and colonoscopy.4,10,11 Furthermore, it has been suggested that capnography may lead to unnecessary procedure interruption, delay, or termination, contributing to inefficiency.4 Thus, most guidelines for gastrointestinal sedation do not recommend routine use of capnography, but recommend it only in specific situations including high-risk patients, intended deep sedation, and long procedures such as endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasonography (EUS).4,11,12
The aim of the current meta-analysis was to determine whether the addition of capnography to standard monitoring including pulse oximetry reduces hypoxemic events during gastrointestinal endoscopic sedation.
In this systematic review, determination of the criteria for the selection of studies, extraction of relevant data, assessment of study quality, and statistical analyses were conducted and reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses statement.13
We conducted a systematic literature search using MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials updated from 1979 to January 2018. The following Medical Subject Heading terms were used: “capnography”, “hypoxia”, “monitoring”, “physiologic”, “endoscopy”, “endoscopic”, “gastrointestinal”, “gastroscopy”, “gastroscopes”, “colonoscopy”, and “colonoscopes”. All of these items were then explored to include secondary headings, and the reports considered were limited to those involving human subjects. Two investigators (SHK and YSC) independently reviewed all potentially relevant material to determine whether or not it met the inclusion criteria.
Inclusion and exclusion criteria and definitions
The inclusion criteria were as follows: 1) study population, patients undergoing gastrointestinal endoscopic sedation; 2) intervention, capnography monitoring; control, standard monitoring; 3) outcome measure, the incidence of oxygen desaturation; and 4) study design, prospective and randomized controlled trials (RCTs). Duplicate publications, review articles, case reports, studies without raw data available for retrieval, and studies only available as abstracts from conferences were excluded.
Evaluation criteria for endpoints
The primary endpoint of this study was the weighted summary OR of the incidence of hypoxemia (SpO2 of <90% to <95%) with a 95% CI. The secondary endpoints were 1) incidence of severe hypoxemia defined as SpO2 of <85%; 2) incidence of apnea; 3) early detection of apnea; 4) use of assisted ventilation; 5) use of supplemental oxygen; 6) bradycardia; 7) hypotension; 8) incidence of early procedure termination; 9) patient satisfaction; and 10) patient cooperation with regard to the endoscopic procedure.
Study selection and data extraction
After removing duplicate studies, two investigators (SHK and YSC) independently perused the titles and abstracts of all publications retrieved and assessed their eligibility for inclusion in the meta-analysis. If available, the full texts of selected studies were screened with reference to the inclusion and exclusion criteria. Selected full-text articles were critically appraised for relevance and validity. When any disagreement occurred, this was resolved by discussion, together with clinical expert consultation. The following information was extracted from the articles included: first author, year of publication, endoscopic procedure, monitoring intervention, patients’ baseline characteristics, sedative agents, depth of sedation, duration of procedures, and primary and secondary outcomes. To avoid bias in the data extraction process, two investigators (SHK and YSC) independently evaluated each study quality and compared results with one another. In case of disagreement, the third investigator (EK) made a determination decision.
Assessment of methodological quality
The Cochrane Collaboration’s risk of bias tool was used to assess the risk of bias in all included studies. The following items were assessed and recorded: random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), and selective reporting (reporting bias).
GRADE assessment and summary of findings
We used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the quality of the evidence associated with specific outcomes (hypoxemia, severe hypoxemia, incidence of apnea, and detection of apnea) in our review and to construct a “summary of findings” table. The GRADE approach considers study risk of bias (methodological quality), directness of the evidence, heterogeneity of the data, precision of effect estimates, and risk of publication bias.
All analyses were performed using Meta V.4.9–0 and Meta for V.2.0–0 in R packages (R language version 3.4.3; R Foundation for Statistical Computing, Vienna, Austria). We calculated the OR as a summary statistic with a 95% CI for dichotomous outcomes and the standardized mean difference with a 95% CI for continuous outcomes. Heterogeneity among the studies was measured using the I2 statistic and the P-value was derived from the Cochran’s Q test. Significant between-study heterogeneity was deemed to be present when there was an I2 value of more than 50% or a Cochran’s Q test P-value of <0.1.14 The presence of publication bias was evaluated via Egger’s test with a funnel plot.15
Identification of studies
Nine studies derived from eight RCTs6,7,9,16–20 in which a total of 3,088 patients who underwent gastrointestinal procedural sedation were enrolled were ultimately included in the final analysis (Figure 1). Overall, 1,542 patients were assigned to the capnography group, and the remaining 1,546 were assigned to the standard monitoring group.
Figure 1 Flow diagram of study searching and selection process.
Study characteristics and patient populations
Of the eight studies, four were performed in Germany, three were performed in the USA, and one was performed in Denmark. Endoscopic procedures included upper endoscopy, colonoscopy, EUS, ERCP, and other interventional procedures. One study, published by Mehta et al,6 provided separate data on colonoscopy and esophagogastroduodenoscopy. Five studies used propofol as a sedative agent7,9,18–20 and other studies used either fentanyl, midazolam, meperidine, or ketamine, or combination of these.6,16,17 The main characteristics of the studies are presented in Table 1.
Apnea was defined as the absence of respiratory activity denoted by a flat line on the capnograph in 7 studies,6,7,9,16,17,19,20 and hypoventilation was defined as a respiratory rate of less than or equal to 8/min in two studies.6,19 In another two studies,6,17 greater than a 75% reduction in the amplitude of the capnograph waveform compared with baseline for 5–10 seconds was defined as abnormal or disordered ventilation.
In five of the eight studies, the endoscopy team (physicians and nurses) was not blinded to the assignment of patients. Capnographic data were available for the capnography group, but not for the standard monitoring group. In the other three studies,6,16,17 the endoscopy team was not aware of the capnographic findings, and capnographic data were only available to an independent observer. In these three studies, interventions were initiated in both groups based on capnography, albeit at different intervals (5–10 seconds for abnormal ventilation in the capnography group and >30 seconds for apnea in the standard monitoring group).
The studies included in this meta-analysis utilized four types of capnography. The Capnostream 20 (Oridion Medical, Needham, MA, USA) was used in four studies, and the other four studies used Capnostream 20 (Covidien, Mansfield, MA, USA), Philips M4 with Microstream CO2 (Philips Medical Systems, Andover, MA, USA; Oridion), Microcap (Oridion), and Philips MP 20 monitor, respectively.
Quality of the included studies
The risks of performances and outcome assessment biases were substantial due to lack of blinding. In five studies, neither the patients nor the endoscopy team was blinded, and there were no independent observers for the outcome assessment. The overall quality of the studies was moderate to low using the GRADE approach. We have included the risk of bias and a summary of findings in Tables S1 and S2, respectively.
All studies reported hypoxemia, with the definitions varying from SpO2 of <90% to <95%. The study by Lightdale et al16 was performed in pediatric patients, and the definition of hypoxemia was SpO2 <95%, which was higher than that of the other studies. In another studies,6,7,9,17–20 SpO2 of <90%–<92% was the criterion for hypoxemia. Publication bias was assessed by Egger’s test with a funnel tunnel plot (P=0.691).
The analysis revealed that capnography significantly reduced the incidence of hypoxemia (OR 0.61, 95% CI 0.49–0.77) (Figure 2). Six studies reported severe hypoxemia, defined as SpO2 of <85%. The analysis showed that the addition of capnography to standard monitoring has benefit in reducing the incidence of severe hypoxemia (OR 0.53, 95% CI 0.35–0.81) (Figure 3).
Figure 2 Forest plot showing the odds ratios and 95% CIs of each study for hypoxemia.
Figure 3 Forest plot showing the odds ratios and 95% CIs of each study for severe hypoxemia.
Apnea was assessed with capnography in four studies, and the incidence of apnea was comparable between the two groups (OR 0.74, 95% CI 0.39–1.43) (Figure 4). In these four studies, capnography was used to detect apnea in both groups. In three studies, the endoscopy team was unaware of the capnographic findings, and apnea was assessed by an independent observer. In the remaining study, the endoscopy team was not blinded to the capnographic findings, and the incidence of apnea was retrospectively analyzed in the standard monitoring group.
Figure 4 Forest plot showing the odds ratios and 95% CIs of each study for the incidence of apnea.
In another two studies, apnea was more frequently detected in the capnography group than in the control group (OR 44.76, CI 25.35–79.04) (Figure 5). In these two studies, capnography was only used in the capnography group and was not used to detect apnea in the standard monitoring group.
Figure 5 Forest plot showing the odds ratios and 95% CIs of each study for the detection of apnea.
Assisted ventilation and supplemental oxygen
Five studies reported on the use of assisted ventilation, and there was no evidence of heterogeneity (I2=0%). The fixed effect model demonstrated that the need to provide assisted ventilation was comparable between the two groups (OR 0.56, 95% CI 0.25–1.22). The need to provide supplemental oxygen was reported in five studies, and analysis indicated that the provision of supplemental oxygen was comparable in the two groups (OR 0.74, 95% CI 0.52–1.03).
Other side effects
Seven studies reported bradycardia, with definitions varying from heart rates of <50 beats/min to <60 beats/min. Hypotension (systolic blood pressure varying from <100 mmHg to <80 mmHg) was reported in eight studies. The incidences of bradycardia (OR 1.18, 95% CI 0.84–1.65) and hypotension (OR 0.92, 95% CI 0.68–1.25) did not differ significantly between the two groups. Four studies reported the incidence of procedure termination secondary to concerns for patient safety, and there were no significant differences in early procedure termination (OR 4.96, 95% CI 0.24–104.39). Three studies reported patient satisfaction outcome and patient cooperation. Neither patient satisfaction (standard mean difference (SMD) −0.02, 95% CI −0.14 to 0.10) nor patient cooperation (SMD 0.00, 95% CI −0.12 to 0.11) differed significantly between the two groups.
Recently, the use of sedatives has improved patient comfort and their acceptance of gastrointestinal endoscopy.21 Interventional endoscopic procedures under endoscopic sedation via a sedative agent such as propofol are now used widely.4 During endoscopic sedation, cardiorespiratory complications such as hypoxemia and apnea may occur, and require technical monitoring including pulse oximetry. However, this method only provides an indirect measure of respiratory function, and the detection of cardiorespiratory depression may potentially be delayed.22
Capnography facilitates continuous, real-time, non-invasive measurement of expiratory CO2. Capnography monitoring entails the measurement of end-tidal CO2 concentrations using an infrared sensor attached to a nasal cannula or face mask.12 This facilitates the early detection of arterial oxygen desaturation via near real-time graphic assessment of respiratory activity. Many studies of surgical operations and non-surgical procedures have shown that the use of capnography monitoring is associated with a reduction in the incidence of hypoxemic events. Nevertheless, the use of capnography during gastrointestinal endoscopy is not an established recognized standard for monitoring respiratory function.
In a recent meta-analysis,23 there was a lack of convincing evidence that the addition of capnography to standard monitoring in emergency departments reduced the rate of adverse events including hypoxemia. However, most of the procedures included in that analysis were orthopedic manipulation, abscess incision and drainage, or cardioversion, which differ from elective procedures. In another meta-analysis including gynecologic procedures, abortion, and emergency department procedures,24,25 capnography reduced the rate of hypoxemia, which is consistent with the results of the current meta-analysis. Notably, there was no consensus on whether capnography could reduce the need for assisted ventilation in those two studies. Further, there was no previously published meta-analysis of the use of capnography during gastrointestinal endoscopic sedation.
In previous sedation guidelines for non-anesthesiologists, continuous monitoring via visual observation of breathing and its frequency was recommended, but capnography monitoring was not mandatory.26 However, recent standards advocated by the American Society of Anesthesiologists suggest that the adequacy of ventilation should be evaluated via continuous capnography monitoring.27
The results of our meta-analysis show that capnography reduced the rate of hypoxemia during gastrointestinal sedation but was not significantly associated with incomplete endoscopic procedures or patient satisfaction. Many factors can influence respiratory depression, such as the degree and depth of sedation, the sedative agents used, the patient’s baseline disease status, age, and the duration of the procedure during endoscopy. The nine studies assessed in the current investigation evaluated hypoxemia, and the median procedure times of four studies were >30 minutes. The duration of the procedure is an important risk factor for oxygen desaturation. Therefore, it is expected that the role of capnography will increase in future in conjunction with the ongoing development of interventional endoscopy procedures with long procedure times, and the widespread use of sedatives associated with those procedures.
The results of the current investigation showed that capnography has a beneficial effect by reducing the incidence of hypoxemia and severe hypoxemia during gastrointestinal endoscopic sedation. Because the target level of sedation was equal in both the standard monitoring and capnography groups, the incidence of apnea was not different between the two groups; however, in two studies evaluating the detection of apnea, there was no evidence of heterogeneity and the results showed that apnea was more often detected with the addition of capnography than it was in the standard monitoring group. Whereas most episodes of apnea might remain undetected using standard monitoring with visual assessment of the patient, the use of capnography can facilitate early interventions such as patient stimulation, withholding or reducing sedative medications, and using chin-lift or jaw-thrust maneuvers. Easier detection of apnea via capnography may explain the difference in the incidence of hypoxemia between the two groups, and these results demonstrate the value of adding capnography monitoring during sedation for gastrointestinal procedure.
The target level of sedation in the trials included in this study ranged from moderate to deep sedation. In moderate sedation, spontaneous ventilation is adequate and maintenance of airway patency does not require interventions.5 However, it is not always possible to predict how a patient will respond to specific sedative and analgesic medications. Thus, the level of sedation could become deeper than initially intended. In this meta-analysis, the addition of capnography monitoring was effective in reducing hypoxemia, and it did not increase the rate of early procedure termination. Therefore, we suggest capnography monitoring should be considered for routine monitoring during gastrointestinal endoscopic procedures performed under moderate sedation in the future.
The present meta-analysis had several limitations that should be taken into account when interpreting the results. It included studies that varied with respect to the sedative agents and corresponding doses used. This may account for some of the heterogeneity in the results of the analysis. Second, because our analysis was based on only eight RCTs, we did not perform subgroup analysis based on the type of endoscopic procedure. Thus, it cannot be decisively concluded that diagnostic and therapeutic endoscopy have similar safety with regard to sedation. We also analyzed both upper endoscopy through the oral cavity and colonoscopy together. Further studies with larger numbers of patients are warranted to clarify the beneficial effects of capnography during gastrointestinal endoscopic sedation.
In the current meta-analysis, capnography monitoring was associated with reduced incidence of hypoxemia during gastrointestinal procedural sedation, and there was no evidence of an association with procedural interruption. Capnography monitoring should be considered in routine monitoring in the near future.
All authors contributed toward data analysis, drafting and critically revising the paper and agree to be accountable for all aspects of the work.
The authors report no conflicts of interest in this work.
Abraham NS, Fallone CA, Mayrand S, Huang J, Wieczorek P, Barkun AN. Sedation versus no sedation in the performance of diagnostic upper gastrointestinal endoscopy: a Canadian randomized controlled cost-outcome study. Am J Gastroenterol. 2004;99(9):1692–1699.
Hart R, Classen M. Complications of diagnostic gastrointestinal endoscopy. Endoscopy. 1990;22(5):229–233.
Daneshmend TK, Bell GD, Logan RF. Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut. 1991;32(1):12–15.
Dumonceau JM, Riphaus A, Schreiber F, et al. Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline – Updated June 2015. Endoscopy. 2015;47(12):1175–1189.
American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96(4):1004–1017.
Mehta PP, Kochhar G, Albeldawi M, et al. Capnographic Monitoring in Routine EGD and Colonoscopy With Moderate Sedation: A Prospective, Randomized, Controlled Trial. Am J Gastroenterol. 2016;111(3):395–404.
Beitz A, Riphaus A, Meining A, et al. Capnographic monitoring reduces the incidence of arterial oxygen desaturation and hypoxemia during propofol sedation for colonoscopy: a randomized, controlled study (ColoCap Study). Am J Gastroenterol. 2012;107(8):1205–1212.
Vargo JJ, Zuccaro G, Dumot JA, Conwell DL, Morrow JB, Shay SS. Automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy. Gastrointest Endosc. 2002;55(7):826–831.
Klare P, Reiter J, Meining A, et al. Capnographic monitoring of midazolam and propofol sedation during ERCP: a randomized controlled study (EndoBreath Study). Endoscopy. 2016;48(1):42–50.
Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy, Lichtenstein DR, Jagannath S, et al. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2008;68(5):815–826.
American Association for Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association Institute, et al. Multisociety sedation curriculum for gastrointestinal endoscopy. Gastrointest Endosc. 2012;76(1):e1–e25.
Dumonceau JM, Riphaus A, Aparicio JR, et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy. 2010;42(11):960–974.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012.
Bown MJ, Sutton AJ. Quality control in systematic reviews and meta-analyses. Eur J Vasc Endovasc Surg. 2010;40(5):669–677.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
Lightdale JR, Goldmann DA, Feldman HA, Newburg AR, Dinardo JA, Fox VL. Microstream capnography improves patient monitoring during moderate sedation: a randomized, controlled trial. Pediatrics. 2006;117(6):e1170–e1178.
Qadeer MA, Vargo JJ, Dumot JA, et al. Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology. 2009;136(5):1568–1576.
Slagelse C, Vilmann P, Hornslet P, Jørgensen HL, Horsted TI. The role of capnography in endoscopy patients undergoing nurse-administered propofol sedation: a randomized study. Scand J Gastroenterol. 2013;48(10):1222–1230.
Friedrich-Rust M, Welte M, Welte C, et al. Capnographic monitoring of propofol-based sedation during colonoscopy. Endoscopy. 2014;46(3):236–244.
Riphaus A, Wehrmann T, Kronshage T, et al. Clinical value of the Integrated Pulmonary Index® during sedation for interventional upper GI-endoscopy: A randomized, prospective tri-center study. Dig Liver Dis. 2017;49(1):45–49.
Riphaus A, Wehrmann T, Weber B, et al. S3-guidelines – sedation in gastrointestinal endoscopy. Z Gastroenterol. 2008;46(11):1298–1330.
Bell GD. Preparation, premedication, and surveillance. Endoscopy. 2004;36(1):23–31.
Wall BF, Magee K, Campbell SG, Zed PJ. Capnography versus standard monitoring for emergency department procedural sedation and analgesia. Cochrane Database Syst Rev. 2017;3:Cd010698.
Saunders R, Struys M, Pollock RF, Mestek M, Lightdale JR. Patient safety during procedural sedation using capnography monitoring: a systematic review and meta-analysis. BMJ Open. 2017;7(6):e013402.
Conway A, Douglas C, Sutherland JR. A systematic review of capnography for sedation. Anaesthesia. 2016;71(4):450–454.
Knape JT, Adriaensen H, van Aken H, et al. Guidelines for sedation and/or analgesia by non-anaesthesiology doctors. Eur J Anaesthesiol. 2007;24(7):563–567.
Anesthesiologists Aso. ASA standards for basic anesthetic monitoring, committee of origin: standards and practice parameters; 2017.
Table S1 Risk of bias summary
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]